Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma

Human Pathology

Volumn 45, Issue 7, 2014, Pages 1430-1436

  Zhang, Haoshaqiang ^a   Yin, Zongsheng ^a   Ning, Kai ^b   Wang, Lei ^b   Guo, Rui ^b   Ji, Zhe ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Xinjiang Uygur Autonomous Region People's Hospital   (China)

Author keywords

Clinicopathological features; Disease free survival; Epithelial cell transforming sequence 2; MicroRNA 223; Osteosarcoma; Overall survival

Indexed keywords

CISPLATIN; DOXORUBICIN; ECT2 PROTEIN; IFOSFAMIDE; MESSENGER RNA; METHOTREXATE; MICRORNA 223; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE TISSUE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CHILD; CHONDROBLASTOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FEMUR TUMOR; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMERUS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OSTEOBLASTOMA; OSTEOSARCOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR NECROSIS; UPREGULATION; WIDE EXCISION;

CLINICOPATHOLOGICAL FEATURES; DISEASE-FREE SURVIVAL; EPITHELIAL CELL TRANSFORMING SEQUENCE 2; MICRORNA-223; OSTEOSARCOMA; OVERALL SURVIVAL;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OSTEOSARCOMA; PROGNOSIS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84903186045     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.02.018     Document Type: Article

References (34)

1. J. Yang, and W. Zhang New molecular insights into osteosarcoma targeted therapy Curr Opin Oncol 25 2013 398 406
2. J. Gill, M.K. Ahluwalia, D. Geller, and R. Gorlick New targets and approaches in osteosarcoma Pharmacol Ther 137 2013 89 99
3. J. Ritter, and S.S. Bielack Osteosarcoma Ann Oncol 21 2010 vii320 vii325
4. T.S. Osborne, and C. Khanna A review of the association between osteosarcoma metastasis and protein translation J Comp Pathol 146 2012 132 142
5. S. Poletajew, L. Fus, and A. Wasiutyński Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors Ortop Traumatol Rehabil 13 2011 537 545
6. J. PosthumaDeBoer, M.A. Witlox, G.J. Kaspers, and B.J. van Royen Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature Clin Exp Metastasis 28 2011 493 503
7. J. Chou, P. Shahi, and Z. Werb MicroRNA-mediated regulation of the tumor microenvironment Cell Cycle 12 2013 3262 3271
8. J. Miao, S. Wu, Z. Peng, M. Tania, and C. Zhang MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects Tumour Biol 34 2013 2093 2098
9. G. Zhou, X. Shi, J. Zhang, S. Wu, and J. Zhao MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review J Int Med Res 41 2013 1 12
10. W. Liang, B. Gao, P. Fu, S. Xu, Y. Qian, and Q. Fu The miRNAs in the pathgenesis of osteosarcoma Front Biosci (Landmark Ed) 18 2013 788 794
11. Y. Mu, H. Zhang, L. Che, and K. Li Clinical significance of microRNA-183/ezrin axis in judging the prognosis of patients with osteosarcoma Med Oncol 31 2014 821
12. H. Zhao, M. Li, L. Li, X. Yang, G. Lan, and Y. Zhang miR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis PLoS One 8 2013 e83571
13. Z. Wang, H. Cai, L. Lin, M. Tang, and H. Cai Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma Pediatr Blood Cancer 61 2014 206 210
14. C.Z. Chen, L. Li, H.F. Lodish, and D.P. Bartel MicroRNAs modulate hematopoietic lineage differentiation Science 303 2004 83 86 (Pubitemid 38055775)
15. E.M. Pinatel, F. Orso, and E. Penna et al. miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions PLoS One 9 2014 e84859
16. X. He, X. Sai, and C. Chen et al. Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy Parasit Vectors 6 2013 272
17. G. Li, M. Cai, and D. Fu et al. Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma Cell Physiol Biochem 30 2012 1481 1490
18. J. Xu, Q. Yao, and Y. Hou et al. miR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation Biomed Pharmacother 67 2013 381 386
19. G. Bacci, F. Bertoni, and A. Longhi et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor Cancer 97 2003 3068 3075 (Pubitemid 36676262)
20. J.S. Earle, R. Luthra, and A. Romans et al. Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma J Mol Diagn 12 2010 433 440
21. L.Y. McGirt, C.M. Adams, D.A. Baerenwald, J.P. Zwerner, J.A. Zic, and C.M. Eischen miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma J Invest Dermatol 134 2014 1101 1107
22. B. Stamatopoulos, N. Meuleman, and B. Haibe-Kains et al. MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification Blood 113 2009 5237 5245
23. Y.H. Yu, L. Zhang, and D.S. Wu et al. miR-223 regulates human embryonic stem cell differentiation by targeting the IGF-1R/Akt signaling pathway PLoS One 8 2013 e78769
24. C. Wu, M. Li, C. Hu, and H. Duan Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma Mol Biol Rep 41 2014 1257 1266
25. Y.W. Dong, R. Wang, and Q.Q. Cai et al. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells J Hepatol 60 2014 792 801
26. K. Zhou, S. Yi, and Z. Yu et al. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia Leuk Lymphoma 53 2012 1155 1161
27. A. Laios, S. O'Toole, and R. Flavin et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer Mol Cancer 7 2008 35
28. T. Miki Interaction of ect2 and Dbl with Rho-related GTPases Methods Enzymol 256 1995 90 98
29. L.P. Huff, M.J. Decristo, and D. Trembath et al. The role of Ect2 nuclear RhoGEF activity in ovarian cancer cell transformation Genes Cancer 4 2013 460 475
30. A. Weeks, N. Okolowsky, B. Golbourn, S. Ivanchuk, C. Smith, and J.T. Rutka ECT2 and RASAL2 mediate mesenchymal-amoeboid transition in human astrocytoma cells Am J Pathol 181 2012 662 674
31. D. Hirata, T. Yamabuki, and D. Miki et al. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression Clin Cancer Res 15 2009 256 266
32. M.L. Zhang, S. Lu, L. Zhou, and S.S. Zheng Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer Hepatobiliary Pancreat Dis Int 7 2008 533 538
33. M. Iyoda, A. Kasamatsu, and T. Ishigami et al. Epithelial cell transforming sequence 2 in human oral cancer PLoS One 5 2010 e14082
34. M.C. Srougi, and K. Burridge The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage PLoS One 6 2011 e17108